Drugs · Brain health technique
Valacyclovir
Evidence grade: Experimental

An oral antiviral medication (Valtrex®, the prodrug of acyclovir) used for HSV-1 and HSV-2 infections; being studied as a potential therapy to reduce viral reactivation implicated in Alzheimer’s risk.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Neuroprotective & Disease-modifying Therapies
- Health domains
- inflammation
- Evidence grade
- Experimental
- Strength of evidence
- Low
- Cost
- High
- Effort
- Low
- Time commitment
- Low
How to practice Valacyclovir
Approved for antiviral use (cold sores, shingles, genital herpes) but not dementia prevention. For typical antiviral indications: 500–1000 mg orally 1–2× daily as prescribed upon outbreaks. Consider speaking to a physician about suppression (daily) therapy to prevent subclinical outbreaks that could increase dementia risk - though note this is an experimental use case.
The evidence behind Valacyclovir
Valacyclovir is an antiviral medicine that stops herpes viruses from copying themselves. It's an approved, well-established treatment for cold sores, genital herpes, and shingles. In small pilot trials, it also lowered viral activity and markers of inflammation.
Impact on brain health
Observational studies link long-term herpes virus infection to a higher risk of Alzheimer's. The idea is that keeping the virus in check could limit brain inflammation and amyloid buildup, but that is unproven. In the one completed randomized trial, people with early Alzheimer's who took valacyclovir for 18 months declined faster in memory and thinking than those on placebo, with no change in amyloid, so valacyclovir isn't a dementia treatment today.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.